Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON51688
NL-OMON51688
Recruiting
Not Applicable

A randomized controlled trial to investigate the (cost)effectiveness of oral immunotherapy with different allergens in young children with an established food allergy. - A RCT on oral immunotherapy in young children with food allergy.

Deventer Ziekenhuis0 sites500 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsFood allergie10001708

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Food allergie
Sponsor
Deventer Ziekenhuis
Enrollment
500
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- 9 to 30 months of age at inclusion.
  • •\- an IgE\-mediated food allergy to peanut, cashew, hazelnut, walnut, cow\*s milk
  • •and/or hen\*s egg as proven by sensitization to the specific allergen (sIgE \>
  • •0\.35kU/l) and a positive oral food challenge.
  • •\- The fore\-mentioned allergens are introduced into the diet of the child (the
  • •child is tolerant for the specific allergen(s)), or the child is diagnosed with
  • •a food allergy for the specific allergen(s).
  • •\- Informed consent is given by parent(s) or guardian(s).

Exclusion Criteria

  • •\- (suspected) eosinophilic oesophagitis
  • •\- uncontrolled asthma/ viral wheeze.
  • •\- the inability of parents to follow instructions, recognize allergic reactions
  • •or administer emergency medication.
  • •\- participation in any other intervention study at the time of the OIT study,
  • •with the exception of studies on guided early introduction of highly allergenic

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A randomized controlled trial for investigating a novel integrated care concept (NICC) for patients suffering from chronic cardiovascular disease: CardioCare MVI50I10I48Heart failureEssential (primary) hypertensionAtrial fibrillation and flutter
DRKS00013124niversitätsmedizin Rostock964
Not yet recruiting
Phase 3
Clinical trial to study the efficacy of Vidangadi Mandura in panduroga with special reference to iron deficiency anaemia between age 6 to 12 years.Health Condition 1: D509- Iron deficiency anemia, unspecified
CTRI/2024/08/072272Dr Shubhangi Rajendra Divekar
Completed
Not Applicable
A clinical trial to study the effect of tranexaemic acid in head neck surgeriesHealth Condition 1: C07- Malignant neoplasm of parotid glandHealth Condition 2: null- Patients suffering with different head and neck cancers and fit to undergo surgeryHealth Condition 3: C775- Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes
CTRI/2017/10/010064il92
Not yet recruiting
Not Applicable
Effect Of Triphala Kwath Parisheka(Stye).Health Condition 1: H000- Hordeolum (externum) (internum) ofeyelid
CTRI/2024/08/072323Dr Shivani Virkar
Not yet recruiting
Phase 2
Effect of Devdaru Choorna in Prameha (Diabetes Mellitus Type 2)Health Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2024/08/072285Dr Samiksha Bhure